
Daniel Edmonston
Assistant Professor of Medicine · Duke Department of Medicine
Credentials: ·
History
- Present
Duke Department of Medicine
- Present
Duke Clinical Research Institute
Research
FGF23 at the crossroads of phosphate, iron economy and erythropoiesis
Review · Nature Reviews Nephrology · 2020 · First of 2 authors · 208 citations
Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic
Nature Reviews Nephrology · 2020 · 192 citations
The Lancet Respiratory Medicine · 2021 · 180 citations

16 papers

7 papers

6 papers

4 papers

4 papers

3 papers

3 papers

3 papers
Grants
- 2021–2027
Novel Mechanisms and Therapeutic Targets for Pulmonary Hypertension in End-Stage Renal Disease (K23)
National Heart, Lung, and Blood Institute · K23
Contact PI · $921K · Duke University
Clinical trials
- 2026–2027
Principal investigator · Withdrawn · Phase 1, Phase 2
Duke University


